Safety and ImmunogenicityAmong Children Administered Quadrivalent Influenza Vaccine

Project Details

StatusFinished
Effective start/end date9/11/10 → 9/11/11

Funding

  • Sanofi Pasteur, Inc.: $137,600.00

Keywords

  • Biotechnology & Drug Development